Dr Jordan Hansford

KEY COLLABORATIONS AND RESEARCH • Clinical research o Site PI – Children’s Oncology Group o National PI – OZM077: COZMOS Phase 1/1b o National PI – OZM063: Avastin-Vinblastine in LGG o National Vice PI – AIM/MNP methylation study o National Vice PI – BIOMEDE o National AI – PRISM o National AI – NORTH o Site PI Pharma studies:  Abbvie  Novartis  BMS  LOXO o International CNS-PNET meta-analysis group – Dr. Annie Huang, Dr. Marcel Kool, Dr. Katja Von Hoff • Basic research o International collaborations supplying tissue and patient data  Ependymoma – Vijay Ramaswamy and Michael D. Taylor, Hospital for Sick Children, Toronto Canada  Constitutional Mismatch Repair Consortium – Uri Tabori, Hospital for Sick Children, Toronto, Canada  Rare embryonal tumours - Dr. Annie Huang, Hospital for Sick Children, Toronto, Canada  Medulloblastoma – Steve Clifford Newcastle University, UK  P53 Working group – Prof. David Malkin, Hospital Hospital for Sick Children, Toronto Canada  DIPG registry Cincinnati Childrens  Methylation in CNS tumours - DKFZ Heidelberg  Neurocognition – Don Mabbott, Hospital for Sick Children, Toronto Canada o National collaborations supplying tissue, data and supervision/oversight  A/Prof. David Ziegler, Sydney Children’s Hospital, University of NSW; DIPG  Dr. Misty Jenkins, WEHI, Melbourne Victoria; CART development DIPG/HG  A/Prof.

Nick Gottardo, Ependymoma/Medulloblastoma – PCH, Perth, WA  Prof. Brandon Wainwright, QIMR, Medulloblastoma  Prof. Greig de Zubicaray, QUT, Neurocognitive imaging  Prof. Claire Wakefield – DELTA tool, Sydney, NSW

Find out more about Jordan Hansford's experience

Jordan Hansford's highlights

FEATURED Journal article

Pattern of Relapse and Treatment Response in WNT-Activated Medulloblastoma.

Jordan Hansford's selected work

Int – 556 & Targeting Site Specific Improvements Of Clinical Trial Operational Processes

Research Contracts

Pineoblastoma segregates into molecular sub-groups with distinct clinico-pathologic featur..

Journal article

“Balancing Expectations with Actual Realities”: Conversations with Clinicians and Scientis..

Journal article

Efficacy and Safety of Dabrafenib in Pediatric Patients with BRAF V600 Mutation-Positive R..

Journal article

Increasing access to clinical trials for adolescents and young adults (AYA) with cancer

Conference Proceedings

Alterations in ALK/ROS1/NTRK/MET drive a group of infantile hemispheric gliomas.

Journal article

Projects

Displaying the most recent project by Jordan Hansford.

Int – 556 & Targeting Site Specific Improvements Of Clinical Trial Operational Processes

2019 - 2019

Completed

1

Projects

Project Types

Research Contracts

Additional Information

2019 ABCM/MRFF- CI- OZM-077 COZMOS Phase 1/1b clinical trial –- $250000 2019 ABCM MRFF – CI - CART development - $600000 2018 NHMRC – AI -The economic impact of precision medicine in high risk and aggressive childhood cancer

351693 2018 Victorian Cancer Council Grant- CI – CAR-T Development Dr. Misty Jenkins $300000 2018 Cancer Australia – CI - OZM-063 – Avastin – Vinblastine Randomized Phase II - $506419 2017 NHMRC – AI -A phase II study of continuous low dose LBH 589 (Panobinostat) with refractory solid tumours, including CNS tumours $811512 2017 Financial Markets Foundation for Children Grant - CI – CAR-T Development

58000 2017 Carries – Beanies for Brain Cancer – CI - CAR-T for high grade glioma $232000 2017 Robert Connor Dawes Foundation/Cancer Australia - CI – AIM Brain

800000 2016 ANZCHOG – Concept Development Workshop Grant – CI - $5000

Scholarly Works

Displaying the 54 most recent scholarly works by Jordan Hansford.

Pattern of Relapse and Treatment Response in WNT-Activated Medulloblastoma.

Liana Nobre, Michal Zapotocky, Sara Khan, Kohei Fukuoka, Adriana Fonseca, Tara McKeown, David Sumerauer, Ales Vicha, Wieslawa A Grajkowska, Joanna Trubicka, Kay Ka Wai Li, Ho-Keung Ng, Luca Massimi, Ji Yeoun Lee, Seung-Ki Kim, Shayna Zelcer, Alexandre Vasiljevic, Cécile Faure-Conter, Peter Hauser, Boleslaw Lach, et al.

Journal article | 2020 | Cell Reports Medicine

Over the past decade, wingless-activated (WNT) medulloblastoma has been identified as a candidate for therapy de-escalation based ..

Pineoblastoma segregates into molecular sub-groups with distinct clinico-pathologic features: a Rare Brain Tumor Consortium registry study

Bryan K Li, Alexandre Vasiljevic, Christelle Dufour, Fupan Yao, Ben LB Ho, Mei Lu, Eugene I Hwang, Sridharan Gururangan, Jordan R Hansford, Maryam Fouladi, Sumihito Nobusawa, Annie Laquerriere, Marie-Bernadette Delisle, Jason Fangusaro, Fabien Forest, Helen Toledano, Palma Solano-Paez, Sarah Leary, Diane Birks, Lindsey M Hoffman, et al.

Journal article | 2020 | Acta Neuropathologica

“Balancing Expectations with Actual Realities”: Conversations with Clinicians and Scientists in the First Year of a High-Risk Childhood Cancer Precision Medicine Trial

BC McGill, CE Wakefield, K Hetherington, LJ Munro, M Warby, L Lau, V Tyrrell, DS Ziegler, TA O’brien, GM Marshall, D Malkin, JR Hansford, KM Tucker, J Vetsch

Journal article | 2020 | Journal of Personalized Medicine

Precision medicine is changing cancer care and placing new demands on oncology professionals. Precision medicine trials for high-r..

Efficacy and Safety of Dabrafenib in Pediatric Patients with BRAF V600 Mutation-Positive Relapsed or Refractory Low-Grade Glioma: Results from a Phase I/IIa Study.

Darren R Hargrave, Eric Bouffet, Uri Tabori, Alberto Broniscer, Kenneth J Cohen, Jordan R Hansford, Birgit Geoerger, Pooja Hingorani, Ira J Dunkel, Mark W Russo, Lillian Tseng, Kohinoor Dasgupta, Eduard Gasal, James A Whitlock, Mark W Kieran

Journal article | 2019 | Clinical Cancer Research

PURPOSE: Pediatric low-grade glioma (pLGG) is the most prevalent childhood brain tumor. Patients with BRAF V600 mutation-positive ..

Increasing access to clinical trials for adolescents and young adults (AYA) with cancer

Justine Ellis, Anne Woollett, Christie Allan, Nicholas Ball, Peter Choong, Rachel Conyers, Jordan Hansford, Ryan Hehir, Natasha Morello, Sally O'Callaghan, Lisa Orme, Susan Sawyer, Robyn Strong, Leanne Super, Angela Watt, Chris Williams, Jeremy Lewin, Alexandra Robertson

Conference Proceedings | 2019 | ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY

Alterations in ALK/ROS1/NTRK/MET drive a group of infantile hemispheric gliomas.

Ana S Guerreiro Stucklin, Scott Ryall, Kohei Fukuoka, Michal Zapotocky, Alvaro Lassaletta, Christopher Li, Taylor Bridge, Byungjin Kim, Anthony Arnoldo, Paul E Kowalski, Yvonne Zhong, Monique Johnson, Claire Li, Arun K Ramani, Robert Siddaway, Liana Figueiredo Nobre, Pasqualino de Antonellis, Christopher Dunham, Sylvia Cheng, Daniel R Boué, et al.

Journal article | 2019 | Nature Communications

Infant gliomas have paradoxical clinical behavior compared to those in children and adults: low-grade tumors have a higher mortali..

A C19MC-LIN28A-MYCN Oncogenic Circuit Driven by Hijacked Super-enhancers Is a Distinct Therapeutic Vulnerability in ETMRs: A Lethal Brain Tumor

Patrick Sin-Chan, Iqra Mumal, Tannu Suwal, Ben Ho, Xiaolian Fan, Irtisha Singh, Yuchen Du, Mei Lu, Neilket Patel, Jonathon Torchia, Dean Popovski, Maryam Fouladi, Paul Guilhamon, Jordan R Hansford, Sarah Leary, Lindsey M Hoffman, Jean M Mulcahy Levy, Alvaro Lassaletta, Palma Solano-Paez, Eloy Rivas, et al.

Journal article | 2019 | Cancer Cell

Embryonal tumors with multilayered rosettes (ETMRs) are highly lethal infant brain cancers with characteristic amplification of Ch..

ESTABLISHING A MOLECULAR PROFILING SERVICE FOR CHILDREN'S CENTRAL NERVOUS SYSTEM TUMORS IN AUSTIRALASIA - THE AUSTRALIAN AND NEAV ZEALAND CHILDREN'S HAEMATOLOGY AND ONCOLOGY GROUP (ANZCHOG) AIM BRAIN PROJECT

Christine White, Kathryn Kinross, Robyn Strong, David Jones, Stefan Pfister, Jordan Hansford, Nicholas Gottardo, Elizabeth Algar

Conference Proceedings | 2019 | Neuro-Oncology

Report of a bi-allelic truncating germline mutation in TP53

Natasha J Brown, Kanika Bhatia, Julie Teague, Susan M White, Patrick Lo, Jackie Challis, Victoria Beshay, Michael Sullivan, David Malkin, Jordan R Hansford

Journal article | 2019 | Familial Cancer

Use of bevacizumab as a single agent or in adjunct with traditional chemotherapy regimens in children with unresectable or progressive low-grade glioma

Nataliya Zhukova, Revathi Rajagopal, Adrienne Lam, Lee Coleman, Peter Shipman, Thomas Walwyn, Molly Williams, Michael Sullivan, Martin Campbell, Kanika Bhatia, Nicholas G Gottardo, Jordan R Hanford

Journal article | 2019 | CANCER MEDICINE

Personalised medicine in paediatric oncology: Ethical practice outside the clinical trial framework?

Jordan R Hansford

Journal article | 2019 | Journal of Paediatrics and Child Health

Modern paediatric oncology practice has rapidly evolved from a fatal condition at diagnosis in the 1940s to modern survival rates ..

International experience in the development of patient-derived xenograft models of diffuse intrinsic pontine glioma

Maria Tsoli, Han Shen, Chelsea Mayoh, Laura Franshaw, Anahid Ehteda, Danielle Upton, Diana Carvalho, Maria Vinci, Michael H Meel, Dannis van Vuurden, Alexander Plessier, David Castel, Rachid Drissi, Michael Farrell, Jane Cryan, Darach Crimmins, John Caird, Jane Pears, Stephanie Francis, Louise EA Ludlow, et al.

Journal article | 2019 | Journal of Neuro-Oncology

PURPOSE: Diffuse intrinsic pontine glioma is the most aggressive form of high grade glioma in children with no effective therapies..

A novel homozygous germline mutation in TP53 presenting with aggressive synchronous tumours in infancy

NJ Brown, K Bhatia, J Teague, SM White, P Lo, J Challis, V Beshay, M Sullivan, D Malkin, JR Hansford

Conference Proceedings | 2018 | EUROPEAN JOURNAL OF HUMAN GENETICS

Rare embryonal brain tumours

A Fonseca, S Al-Karmi, A Vasiljevic, A Dodghsun, PS Chan, LL Cousin, J Hansford, A Huang

Book Chapter | 2018

Spinal Cord Hyperintensities in Neurofibromatosis Type 1: Are They the Cord Equivalent of Unidentified Bright Objects in the Brain?

Andrea D Ruegger, Lee Coleman, Jordan R Hansford, Natalie McLean, Gabriel Dabscheck

Journal article | 2018 | Pediatric Neurology

Molecularly defined diffuse leptomeningeal glioneuronal tumor (DLGNT) comprises two subgroups with distinct clinical and genetic features

Maximilian Y Deng, Martin Sill, Jason Chiang, Jens Schittenhelm, Martin Ebinger, Martin U Schuhmann, Camelia-Maria Monoranu, Till Milde, Andrea Wittmann, Christian Hartmann, Clemens Sommer, Werner Paulus, Jutta Gaertner, Wolfgang Brueck, Thomas Ruediger, Alfred Leipold, Zane Jaunmuktane, Sebastian Brandner, Felice Giangaspero, Paolo Nozza, et al.

Journal article | 2018 | Acta Neuropathologica

GERM-23. INTRACRANIAL GROWING TERATOMA SYNDROME (IGTS): AN INTERNATIONAL RETROSPECTIVE STUDY.

George Michaiel, Douglas Strother, Nicholas Gottardo, Ute Bartels, Hallie Coltin, David D Eisenstat, Juliette Hukin, Donna L Johnston, Beverly Wilson, Shayna Zelcer, Jordan R Hansford, Olivia Wells, Mohamed S AbdelBaki, Mohammad H Abu-Arja, Kristina A Cole, Girish Dhall, Paul G Fisher, Lindsey Hoffman, Sarah ES Leary, Emily E Owens Pickle, et al.

Journal article | 2018 | Neuro-Oncology

AbstractBACKGROUNDIGTS is a rare phenomenon of paradoxical germ cell tumor (GCT) growth during or following treatment despite norm..

DIPG-69. CHARACTERISTICS OF PATIENTS ≥ 10 YEARS OF AGE WITH DIFFUSE INTRINSIC PONTINE GLIOMA: A REPORT FROM THE INTERNATIONAL DIPG REGISTRY.

Craig Erker, Adam Lane, Brooklyn Chaney, Nancy Yanez Escorza, Christine Fuller, Raya Saab, Mark Kieran, Roger Packer, Javad Nazarian, Jane Minturn, Andrew Dodgshun, Sarah Parkin, Nicholas Foreman, Emmett Broxson, Mercedes Garcia Lombardi, Stewart Goldman, Eric Sandler, Kathy Warren, Robert Greiner, Nickolas Gottardo, et al.

Journal article | 2018 | Neuro-Oncology

AbstractINTRODUCTIONPatients ≥10 years of age with a DIPG are reported to have a higher rate of long-term survival (≥24 months). T..

EMBR-17. PINEOBLASTOMA SEGREGATES INTO MOLECULAR SUBTYPES WITH DISTINCT CLINICOPATHOLOGIC FEATURES: REPORT FROM THE RARE BRAIN TUMOR CONSORTIUM.

Bryan Li, Alexandre Vasiljevic, Ben Ho, Joseph Norman, Mei Lu, Eugene Hwang, Jordan Hansford, Anne Jouvet, Annie Laquerriere, Marie-Bernadette Delisle, Sridharan Gururangan, Jason Fangusaro, Fabien Forest, Nobusawa Sumihito, Helen Toledano, Diane Birks, Xing Fan, Maryam Fouladi, Amar Gajjar, Guillaume Gauchotte, et al.

Journal article | 2018 | Neuro-Oncology

AbstractPineoblastoma (PB) is a rare but aggressive pediatric brain tumour arising from the pineal gland. Outcomes remain dismal w..

MBCL-51. RETROSPECTIVE ANALYSIS OF VICTORIAN PATIENTS DIAGNOSED WITH MEDULLOBLASTOMA BETWEEN 1990-2017.

S Khan, C White, PA Downie, J Hansford, CR Cochrane, A Szczepny, P Siswara, A Sexton-Oates, D McGregor, TB Phung, E Algar, JE Cain

Journal article | 2018 | Neuro-Oncology

AbstractBACKGROUNDMedulloblastoma is the most common yet challenging paediatric brain tumour. No longer considered a single diseas..

HGG-20. DNA METHYLATION ANALYSIS OF HIGH-GRADE GLIOMA IN PATIENTS WITH MISMATCH REPAIR DEFICIENCIES.

Andrew Dodgshun, Kohei Fukuoka, Brittany Campbell, Melissa Edwards, Alexandra Sexton-Oates, Valérie Larouche, Vanan Magimairajan, Scott Lindhorst, Michal Oren, Gary Mason, Bruce Crooks, Shlomi Constantini, Maura Massimino, Stefano Chiaravalli, Jagadeesh Ramdas, Warren Mason, Ashraf Shamvil, Roula Farah, An van Damme, Enrico Opocher, et al.

Journal article | 2018 | Neuro-Oncology

AbstractPatients with constitutional mismatch repair deficiency (CMMRD) are prone to developing high-grade glioma (HGG). These tum..

LGG-59. REMARKABLE OBJECTIVE RESPONSE AND FAVORABLE SURVIVAL FOR BRAF-V600E CHILDHOOD LOW-GRADE GLIOMAS TO BRAF INHIBITORS COMPARED CONVENTIONAL CHEMOTHERAPY.

Michal Zapotocky, Scott Ryall, Kohei Fukuoka, Ana Guerreiro Stucklin, Julie Bennett, David Sumerauer, Zdenek Pavelka, Ofelia Cruz, Palma Solano, Maria Luisa Garre, Peter Hauser, Didier Frappaz, Jordan Hansford, Nisreen Amayiri, Helena Morse, Magnus Sabel, Anne Grete Bechensteen, Jack Su, Matthias Karajannis, Jonathan Finlay, et al.

Journal article | 2018 | Neuro-Oncology

AbstractActivation of the MAPK pathway represents a hallmark of pediatric low-grade glioma (pLGG) and is frequently caused by BRAF..

DNA METHYLATION ANALYSIS OF HIGH-GRADE GLIOMA IN PATIENTS WITH MISMATCH REPAIR DEFICIENCIES

Andrew Dodgshun, Kohei Fukuoka, Brittany Campbell, Melissa Edwards, Alexandra Sexton-Oates, Valerie Larouche, Vanan Magimairajan, Scott Lindhorst, Michal Oren, Gary Mason, Bruce Crooks, Shlomi Constantini, Maura Massimino, Stefano Chiaravalli, Jagadeesh Ramdas, Warren Mason, Ashraf Shamvil, Roula Farah, An van Damme, Enrico Opocher, et al.

Conference Proceedings | 2018 | NEURO-ONCOLOGY

RETROSPECTIVE ANALYSIS OF VICTORIAN PATIENTS DIAGNOSED WITH MEDULLOBLASTOMA BETWEEN 1990-2017

S Khan, C White, PA Downie, J Hansford, CR Cochrane, A Szczepny, P Siswara, A Sexton-Oates, D McGregor, TB Phung, E Algar, JE Cain

Conference Proceedings | 2018 | NEURO-ONCOLOGY

DNA methylation-based classification of central nervous system tumours

David Capper, David TW Jones, Martin Sill, Volker Hovestadt, Daniel Schrimpf, Dominik Sturm, Christian Koelsche, Felix Sahm, Lukas Chavez, David E Reuss, Annekathrin Kratz, Annika K Wefers, Kristin Huang, Kristian W Pajtler, Leonille Schweizer, Damian Stichel, Adriana Olar, Nils W Engel, Kerstin Lindenberg, Patrick N Harter, et al.

Journal article | 2018 | NATURE

Cancer Screening Recommendations and Clinical Management of Inherited Gastrointestinal Cancer Syndromes in Childhood

Maria Isabel Achatz, Christopher C Porter, Laurence Brugieres, Harriet Druker, Thierry Frebourg, William D Foulkes, Christian P Kratz, Roland P Kuiper, Jordan R Hansford, Hector Salvador Hernandez, Katherine L Nathanson, Wendy K Kohlmann, Leslie Doros, Kenan Onel, Kami Wolfe Schneider, Sarah R Scollon, Uri Tabori, Gail E Tomlinson, D Gareth R Evans, Sharon E Plon

Journal article | 2017 | Clinical Cancer Research

Hereditary gastrointestinal cancer predisposition syndromes have been well characterized, but management strategies and surveillan..

Clinical Management and Tumor Surveillance Recommendations of Inherited Mismatch Repair Deficiency in Childhood

Uri Tabori, Jordan R Hansford, Maria Isabel Achatz, Christian P Kratz, Sharon E Plon, Thierry Frebourg, Laurence Brugieres

Journal article | 2017 | Clinical Cancer Research

Replication proofreading is crucial to avoid mutation accumulation in dividing cells. In humans, proofreading and replication repa..

Cancer Screening Recommendations for Individuals with Li-Fraumeni Syndrome

Christian P Kratz, Maria Isabel Achatz, Laurence Brugieres, Thierry Frebourg, Judy E Garber, Mary-Louise C Greer, Jordan R Hansford, Katherine A Janeway, Wendy K Kohlmann, Rose Mcgee, Charles G Mullighan, Kenan Onel, Kristian W Pajtler, Stefan M Pfister, Sharon A Savage, Joshua D Schiffman, Katherine A Schneider, Louise C Strong, D Gareth R Evans, Jonathan D Wasserman, et al.

Journal article | 2017 | Clinical Cancer Research

Li-Fraumeni syndrome (LFS) is an autosomal dominantly inherited condition caused by germline mutations of the TP53 tumor suppresso..

Risk assessment in paediatric glioma-Time to move on from the binary classification

AJ Dodgshun, JR Hansford, MJ Sullivan

Journal article | 2017 | Critical Reviews in Oncology/Hematology

The current consensus on the clinical management of intracranial ependymoma and its distinct molecular variants

Kristian W Pajtler, Stephen C Mack, Vijay Ramaswamy, Christian A Smith, Hendrik Witt, Amy Smith, Jordan R Hansford, Katja von Hoff, Karen D Wright, Eugene Hwang, Didier Frappaz, Yonehiro Kanemura, Maura Massimino, Cecile Faure-Conter, Piergiorgio Modena, Uri Tabori, Katherine E Warren, Eric C Holland, Koichi Ichimura, Felice Giangaspero, et al.

Journal article | 2017 | Acta Neuropathologica

Multiple independent genomic profiling efforts have recently identified clinically and molecularly distinct subgroups of ependymom..

Integrated (epi)-Genomic Analyses Identify Subgroup-Specific Therapeutic Targets in CNS Rhabdoid Tumors

Jonathon Torchia, Brian Golbourn, Shengrui Feng, King Ching Ho, Patrick Sin-Chan, Alexandre Vasiljevic, Joseph D Norman, Paul Guilhamon, Livia Garzia, Natalia R Agamez, Mei Lu, Tiffany S Chan, Daniel Picard, Pasqualino de Antonellis, Dong-Anh Khuong-Quang, Aline C Planello, Constanze Zeller, Dalia Barsyte-Lovejoy, Lucie Lafay-Cousin, Louis Letourneau, et al.

Journal article | 2016 | Cancer Cell

We recently reported that atypical teratoid rhabdoid tumors (ATRTs) comprise at least two transcriptional subtypes with different ..

Genome-Wide DNA Methylation Analysis Reveals Epigenetic Dysregulation of MicroRNA-34A in TP53-Associated Cancer Susceptibility

Nardin Samuel, Gavin Wilson, Mathieu Lemire, Badr Id Said, Youliang Lou, Weili Li, Diana Merino, Ana Novokmet, James Tran, Kim E Nichols, Jonathan L Finlay, Sanaa Choufani, Marc Remke, Vijay Ramaswamy, Florence MG Cavalli, Christine Elser, Lynn Meister, Michael D Taylor, Uri Tabori, Meredith Irwin, et al.

Journal article | 2016 | Journal of Clinical Oncology

PURPOSE: Although the link between mutant TP53 and human cancer is unequivocal, a significant knowledge gap exists in clinically a..

Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency

Eric Bouffet, Valerie Larouche, Brittany B Campbell, Daniele Merico, Richard de Borja, Melyssa Aronson, Carol Durno, Joerg Krueger, Vanja Cabric, Vijay Ramaswamy, Nataliya Zhukova, Gary Mason, Roula Farah, Samina Afzal, Michal Yalon, Gideon Rechavi, Vanan Magimairajan, Michael F Walsh, Shlomi Constantini, Rina Dvir, et al.

Journal article | 2016 | Journal of Clinical Oncology

PURPOSE: Recurrent glioblastoma multiforme (GBM) is incurable with current therapies. Biallelic mismatch repair deficiency (bMMRD)..

Disseminated glioneuronal tumors occurring in childhood: treatment outcomes and BRAF alterations including V600E mutation

Andrew J Dodgshun, Nadine SantaCruz, Jaeho Hwang, Shakti H Ramkissoon, Hayley Malkin, Guillaume Bergthold, Peter Manley, Susan Chi, Duncan MacGregor, Liliana Goumnerova, Michael Sullivan, Keith Ligon, Rameen Beroukhim, Betty Herrington, Mark W Kieran, Jordan R Hansford, Pratiti Bandopadhayay

Journal article | 2016 | Journal of Neuro-Oncology